Health Catalyst Stock Price, News & Analysis

Health Catalyst (Nasdaq: HCAT) has launched Upfront Market Insights on Salesforce AppExchange, enhancing healthcare organizations' ability to engage with patients through data-driven insights. The integration works seamlessly with Salesforce Health Cloud and Marketing Cloud, enabling healthcare providers to leverage advanced personalization features without additional tools or staff.

The solution allows healthcare enterprises to segment contact lists based on psychographics and create targeted patient journeys with personalized content. This integration aims to improve patient engagement in critical screenings, treatments, and healthcare resources through better understanding of patient populations and their unique motivators.

Health Catalyst (NASDAQ: HCAT), a leading healthcare data and analytics technology provider, has announced its participation in three major upcoming investor conferences in September 2025:

• Cantor Global Healthcare Conference in New York on September 3, 2025 at 9:10 AM ET
• Wells Fargo Healthcare Conference in Boston on September 4, 2025 at 1:30 PM ET
• Morgan Stanley 23rd Annual Global Healthcare Conference in New York on September 9, 2025 at 11:30 AM ET

Senior management, including CEO Dan Burton, CFO Jason Alger, and SVP of Finance Matt Hopper, will participate in fireside chats at these events. Webcasts will be available on the company's investor relations website.

Health Catalyst (NASDAQ: HCAT) announced that CEO Dan Burton will step down from his position effective June 30, 2026, to pursue volunteer service opportunities with his wife in support of their faith. Burton, who has led the company for 15 years, will continue to serve on the Board and support the search for a new CEO.

Under Burton's leadership, Health Catalyst grew from a 3-person team to a public company with 1,100 healthcare clients and 1,400 team members. The company achieved over $2.2 billion in client-approved improvements and maintained exceptional team member engagement levels between the 94th and 99th percentile over the past decade, earning more than 125 Best Workplace Awards since 2013.

Health Catalyst (Nasdaq: HCAT) reported strong Q2 2025 financial results, with total revenue of $80.7 million (up 6% YoY) and Adjusted EBITDA of $9.3 million (up 24% YoY), exceeding quarterly guidance. The company maintained a gross margin of 38% and an Adjusted Gross Margin of 50%.

CEO Dan Burton announced his planned retirement effective June 30, 2026, after 15 years of leadership. The Board will conduct a CEO search, with Burton continuing to serve on the Board post-retirement.

For Q3 2025, Health Catalyst expects revenue of approximately $75 million and Adjusted EBITDA of $10.5 million. Full-year 2025 guidance projects revenue of $310 million and Adjusted EBITDA of $41 million.

Health Catalyst (NASDAQ: HCAT), a leading healthcare data and analytics technology provider, has scheduled its second quarter 2025 earnings release for Thursday, August 7, 2025, after market close.

The company will host a conference call at 5:00 PM ET on the same day. U.S. participants can dial 800-343-5172, while international participants should call 203-518-9856 using conference ID "HCATQ225". A live webcast will be available at ir.healthcatalyst.com, with a replay accessible for approximately 90 days.

Health Catalyst (Nasdaq: HCAT) has announced the release of 10 AI-integrated data toolkits on the Databricks Marketplace, marking a significant advancement in healthcare analytics accessibility. These toolkits, available through Delta Sharing at no cost, are specifically designed to address critical healthcare challenges and enable organizations to initiate measurable improvements.

The toolkits incorporate advanced machine learning models, including limited versions of Health Catalyst's Healthcare.AI and large language models (LLM). They target key healthcare areas such as hospital readmission prediction, emergency department visit reduction, HEDIS score improvement, and patient attribution matching. The solution allows healthcare organizations to trial use cases and experience Health Catalyst's domain expertise firsthand.

This initiative follows Health Catalyst's January partnership with Databricks and the April launch of Health Catalyst Ignite Spark™, demonstrating the company's commitment to democratizing healthcare analytics and making data-driven improvements more accessible to organizations of all sizes.

Health Catalyst (NASDAQ: HCAT), a healthcare data and analytics technology provider, has announced its participation in two upcoming investor conferences. The company's Chief Financial Officer Jason Alger and Vice President of Investor Relations Jack Knight will attend:

1. The Stifel Cross Sector 1x1 Conference in Boston on June 3, 2025

2. The Goldman Sachs 46th Annual Global Healthcare Conference in Miami on June 10, 2025

Health Catalyst (NASDAQ: HCAT) reported its Q1 2025 financial results with total revenue of $79.4 million, representing a 6% year-over-year growth, and Adjusted EBITDA of $6.3 million, marking an 86% increase from the previous year. The company successfully added 10 net new Platform Clients in Q1 2025, positioning them well to achieve their target of 40 net new Platform Client additions for the year.

The company's financial metrics showed mixed results, with gross margin declining to 36% from 39% year-over-year, and net loss increasing to $23.7 million. For Q2 2025, Health Catalyst expects revenue of approximately $80.5 million and Adjusted EBITDA of $8 million. The full-year 2025 guidance projects total revenue of $335 million, including technology revenue of $220 million, and Adjusted EBITDA of $41 million.

Health Catalyst and Microsoft have announced a strategic partnership to accelerate AI adoption in healthcare organizations. The collaboration leverages Health Catalyst's expertise with Microsoft Azure and Azure AI Foundry to deliver advanced AI solutions for improved operational, clinical, and financial performance.

Two key solutions - Healthcare.AI™ and Health Catalyst Ignite™ - are immediately available on the Azure Marketplace, with more solutions planned for future release. These tools aim to address challenges in data analytics, cybersecurity, financial, and operational improvement.

The partnership combines Microsoft's AI technology with Health Catalyst's healthcare improvement expertise to deliver sustainable performance improvements for healthcare organizations of all sizes. Leadership from both companies emphasize that successful AI implementation requires both powerful technology and deep healthcare industry knowledge.